Katsuya Ohbuchi

1.1k total citations
63 papers, 871 citations indexed

About

Katsuya Ohbuchi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Katsuya Ohbuchi has authored 63 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 11 papers in Pharmacology. Recurrent topics in Katsuya Ohbuchi's work include RNA regulation and disease (11 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Pharmacological Effects of Natural Compounds (8 papers). Katsuya Ohbuchi is often cited by papers focused on RNA regulation and disease (11 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Pharmacological Effects of Natural Compounds (8 papers). Katsuya Ohbuchi collaborates with scholars based in Japan, United Kingdom and United States. Katsuya Ohbuchi's co-authors include Masahiro Yamamoto, Toru Kono, Atsushi Kaneko, Yasuhito Uezono, Kanako Miyano, Yuji Omiya, Katsumi Aragane, Yoshitaka Tamai, Junji Yamauchi and Yuki Miyamoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Katsuya Ohbuchi

61 papers receiving 857 citations

Peers

Katsuya Ohbuchi

PHYSI

SURGE

PHARM

Yunli Yu China

Koji Ueshima Japan

Emmanuelle Plée‐Gautier France

Youngmin Bu South Korea

Jung Min Oh South Korea

Jing Yan China

Nancy N. Shahin Egypt

Adnan Khan Pakistan

Masateru Yamada Japan

Yunli Yu China

Katsuya Ohbuchi

287 ×0.8

79 ×0.5

PHYSI

77 ×0.6

SURGE

123 ×0.9

PHARM

45 ×0.5

Citations per year, relative to Katsuya Ohbuchi Katsuya Ohbuchi (= 1×) peers Yunli Yu

Countries citing papers authored by Katsuya Ohbuchi

Since Specialization

Citations

This map shows the geographic impact of Katsuya Ohbuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuya Ohbuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuya Ohbuchi more than expected).

Fields of papers citing papers by Katsuya Ohbuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuya Ohbuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuya Ohbuchi. The network helps show where Katsuya Ohbuchi may publish in the future.

Co-authorship network of co-authors of Katsuya Ohbuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuya Ohbuchi. A scholar is included among the top collaborators of Katsuya Ohbuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuya Ohbuchi. Katsuya Ohbuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shirai, Remina, Norio Takagi, Hiroaki Oizumi, et al.. (2024). Rab11a Controls Cell Shape via C9orf72 Protein: Possible Relationships to Frontotemporal Dementia/Amyotrophic Lateral Sclerosis (FTDALS) Type 1. Pathophysiology. 31(1). 100–116. 2 indexed citations

Miyano, Kanako, Miki Nonaka, Masahiro Sakamoto, et al.. (2024). The Inhibition of TREK-1 K+ Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways. International Journal of Molecular Sciences. 25(9). 4907–4907. 1 indexed citations

Miyano, Kanako, Katsuya Ohbuchi, Hiroaki Murata, et al.. (2023). Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses. International Journal of Molecular Sciences. 24(9). 8369–8369. 3 indexed citations

Shirai, Remina, Katsuya Ohbuchi, Hiroaki Oizumi, et al.. (2023). Hesperetin Ameliorates Inhibition of Neuronal and Oligodendroglial Cell Differentiation Phenotypes Induced by Knockdown of Rab2b, an Autism Spectrum Disorder-Associated Gene Product. Neurology International. 15(1). 371–391. 4 indexed citations

Tago, Kenji, Remina Shirai, Hiroaki Oizumi, et al.. (2022). CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological Differentiation. Non-Coding RNA. 8(3). 42–42. 5 indexed citations

Miyamoto, Yuki, Tomohiro Torii, Keiichi Homma, et al.. (2022). The adaptor SH2B1 and the phosphatase PTP4A1 regulate the phosphorylation of cytohesin-2 in myelinating Schwann cells in mice. Science Signaling. 15(718). eabi5276–eabi5276. 7 indexed citations

Shirai, Remina, Hiroaki Oizumi, Masahiro Yamamoto, et al.. (2022). Hesperetin, a Citrus Flavonoid, Ameliorates Inflammatory Cytokine-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation. Neurology International. 14(2). 471–487. 10 indexed citations

Oizumi, Hiroaki, Katsuya Ohbuchi, Kazushige Mizoguchi, et al.. (2022). Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen. Neurology International. 14(1). 212–244. 1 indexed citations

Tago, Kenji, Kazuma Tomizuka, Katsuya Ohbuchi, et al.. (2021). The Infantile Leukoencephalopathy-Associated Mutation of C11ORF73/HIKESHI Proteins Generates De Novo Interactive Activity with Filamin A, Inhibiting Oligodendroglial Cell Morphological Differentiation. SHILAP Revista de lepidopterología. 8(2). 9–9. 9 indexed citations

10.

Tago, Kenji, Hiroaki Oizumi, Katsuya Ohbuchi, et al.. (2021). Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen. Neurology International. 14(1). 11–33. 10 indexed citations

11.

Seki, Yoichi, Takako Morimoto, Hiroaki Oizumi, et al.. (2021). Knockdown of Golgi Stress-Responsive Caspase-2 Ameliorates HLD17-Associated AIMP2 Mutant-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation. Neurochemical Research. 47(9). 2617–2631. 9 indexed citations

12.

Terawaki, Kiyoshi, et al.. (2021). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of Ethnopharmacology. 285. 114896–114896. 6 indexed citations

13.

Nishi, Akinori, Katsuya Ohbuchi, Hirotaka Kushida, et al.. (2021). Publisher Correction: LimeMap: a comprehensive map of lipid mediator metabolic pathways. npj Systems Biology and Applications. 7(1). 16–16. 1 indexed citations

14.

Seki, Yoichi, Takako Morimoto, Hiroaki Oizumi, et al.. (2021). Phospholipase D and phosphatidylinositol-4-phosphate 5-kinase 1 are involved in the regulation of oligodendrocyte morphological differentiation. Experimental Cell Research. 405(1). 112654–112654. 8 indexed citations

15.

Goto, Mizuki, Kenji Tago, Hiroaki Oizumi, et al.. (2021). Hypomyelinating Leukodystrophy 15 (HLD15)-Associated Mutation of EPRS1 Leads to Its Polymeric Aggregation in Rab7-Positive Vesicle Structures, Inhibiting Oligodendroglial Cell Morphological Differentiation. Polymers. 13(7). 1074–1074. 7 indexed citations

16.

Matsumoto, Naoto, Yuki Miyamoto, Akihiro Ito, et al.. (2020). PP1C and PP2A are p70S6K Phosphatases Whose Inhibition Ameliorates HLD12-Associated Inhibition of Oligodendroglial Cell Morphological Differentiation. Biomedicines. 8(4). 89–89. 11 indexed citations

17.

Ohbuchi, Katsuya, Nozomu Sakurai, Hiroyuki Kitagawa, et al.. (2020). 変換代謝産物(DAC-Met)の示差注釈:高分解能質量分析を用いた血漿中のMaoto(Ma-Huang-Tang)誘導代謝産物の探索【JST・京大機械翻訳】. Metabolomics. 16(5). 63. 2 indexed citations

18.

Takeuchi, Yu, Yasuyuki Fukui, Ko Noguchi, et al.. (2020). Rare Neurologic Disease-Associated Mutations of AIMP1 Are Related with Inhibitory Neuronal Differentiation Which Is Reversed by Ibuprofen. SHILAP Revista de lepidopterología. 7(5). 25–25. 5 indexed citations

19.

Takagi, Rie, Masaaki Kawano, Kazuyuki Nakagome, et al.. (2014). Wogonin Attenuates Ovalbumin Antigen-Induced Neutrophilic Airway Inflammation by Inhibiting Th17 Differentiation. International Journal of Inflammation. 2014. 1–8. 17 indexed citations

20.

Harada, Naomoto, Yoshikazu Hara, Katsuya Ohbuchi, et al.. (2007). Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice. Molecular and Cellular Biology. 27(5). 1881–1888. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact